相关实验视频

Updated: Jun 25, 2025

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

综合临床基因型-表型特征的STAT3-突变的骨髓状新生体

Matthew T Ye¹, Zhuang Zuo¹, Steliana Calin¹

¹Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Clinical cancer research : an official journal of the American Association for Cancer Research

|May 20, 2024

概括

在髓状瘤 (MNs) 中,STAT3突变是罕见的,但在疾病进展中起作用. 这些突变通常发生在早期,可以识别那些可能受益于向JAK-STAT途径治疗的患者.

科学领域:

血液学血液学血液学
分子生物学分子生物学
在瘤学瘤学.

背景情况:

信号转换器和转录3激活器 (STAT3) 是参与癌症进展的关键转录因子.
骨髓瘤瘤 (MNs) 中的STAT3激活通常由酸化介导,突变很少发生.
了解MNs中STAT3突变的作用对于开发向疗法至关重要.

研究的目的:

研究STAT3突变骨髓瘤瘤的临床病理学和分子遗传特征.
确定STAT3突变的频率和特征在各种MN亚型中.
探索STAT3突变在MN病原和潜在的治疗策略中的影响.

主要方法:

对32名STAT3突变MNS患者的临床病理学和分子遗传数据的分析.
划分MN亚型包括急性骨髓性白血病,骨髓显样性综合征和慢性骨髓单细胞性白血病.
评估突变时间,克隆层次和共存突变.

主要成果:

在<0.5%的MNs中发现了STAT3突变,主要发生在急性髓性白血病 (62.5%),骨髓显样性综合征 (21.9%) 和慢性骨髓单细胞白血病 (15.6%) 中.
突变通常在初始诊断时 (88%) 或在复发/转变期间发生,通常是SH2域中的误解突变 (Y640F最常见).
STAT3突变与特定的遗传变化 (SRSF2,TET2,ASXL1,SETBP1) 和临床病理特征 (发育不良,弹性细胞增加,单体7/del7q) 相关.

结论:

STAT3突变存在于多种多样性脑瘤中,不包括骨髓增殖性瘤,并且在病变的早期或白血病转变期间出现.
这些突变可能通过JAK-STAT通路激活导致MN进展.
STAT3突变状态可能有助于确定符合有针对性的治疗干预措施的MN患者.

更多相关视频

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

相关概念视频

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...